The cost of immunotherapy with Keytruda (pembrolizumab) in Mexico typically ranges from $7,000 to $11,000. Prices can vary depending on the hospital, oncologist’s experience, number of treatment cycles, and whether additional diagnostics or combination therapies are needed. In the U.S., the average cost is $21,500 (per ASCO). This means immunotherapy with Keytruda in Mexico is about 58% less than in the United States.
Mexican hospitals usually include the Keytruda medication, infusion sessions, oncologist consultations, basic blood tests, and follow-up visits in the package price. In the U.S., costs for the drug, infusion, and monitoring are often billed separately, with hospital and physician fees added on top. Always confirm exactly what’s included with your chosen clinic before starting treatment.
| Mexico | Turkey | Austria | |
| Immunotherapy with Keytruda (Pembolizumab) | from $7,000 | from $7,300 | from $15,000 |
Medically reviewed by
Fahad MawloodNo hidden fees – just official clinic prices. Pay at the clinic for Immunotherapy with Keytruda (Pembolizumab) upon arrival and use a flexible installment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Immunotherapy with Keytruda (Pembolizumab) and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Immunotherapy with Keytruda (Pembolizumab) journey.
Immunotherapy with Keytruda (Pembrolizumab) in Mexico can offer significant cost savings, but it's crucial to weigh the potential benefits against the risks.
| Pros | Cons |
|---|---|
| Lower costs. Keytruda immunotherapy in Mexico costs $5,000–$8,000 per session ($10,000–$16,000 for two sessions), compared to over $150,000 annually in the US, offering savings of 30–50%. | Safety concerns. Potential risks include immune-related side effects (such as fatigue, rash, or colitis), with complication rates similar to US averages. Careful monitoring by experienced oncologists is essential. |
| Qualified oncologists. Many oncologists are certified by the Mexican Council of Oncology, with training in US or European medical centers and experience administering immunotherapies. | Follow-up care. Ongoing monitoring and lab work may be more complex for international patients, though some clinics offer telemedicine and coordinated discharge planning. |
| Modern facilities. Treatments are provided in JCI- or ISO-accredited hospitals, using FDA-approved Keytruda sourced from reputable manufacturers, and following international safety protocols. | Different regulatory standards. COFEPRIS standards differ from the FDA, but top clinics align with international protocols and use the same medication brands as in the US. |
| Access to advanced therapy. Keytruda is available for a range of cancers, and clinics in Mexico offer access with shorter wait times than many US centers. | Immune response risks. Potential risks include immune-mediated reactions, reported in up to 20% of patients. These are managed by experienced oncology teams when performed by qualified professionals. |
| Personal coordinator support. Bookimed’s medical coordinator helps compare clinics, request personalized quotes, and manage treatment logistics at no additional cost. |
It's crucial to thoroughly research clinics and verify oncologist credentials before making a decision. When performed by qualified specialists in accredited facilities, immunotherapy with Keytruda in Mexico can offer safe and cost-effective cancer care.
